brolucizumab · Medicine question

Which conditions is brolucizumab (Beovu) licensed to treat in adults?

Name: Which conditions is brolucizumab (Beovu) licensed to treat in adults?
Published: 2026-11-08T01:38:59.116Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Brolucizumab (Beovu) is indicated in adults for neovascular (wet) age-related macular degeneration and visual impairment due to diabetic macular oedema.

Sources for this answer

Beovu 120 mg/ml solution for injection in pre filled syringeNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 11Document updated 25 July 2025

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about brolucizumab